BioSpace News Archive

Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value ta

Masimo (Nasdaq: MASI) today announced its financial results for the second quarter ended June 27, 2020.

New data presented today by an international research team at the Alzheimer’s Association International Conference (AAIC) and published simultaneously in JAMA reports that a newly validated, highly accurate test that measures blood levels of p-tau217 can accurately distinguish Alzheimer’s from other neurodegenerative disorders.

Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”) , a vertically integrated cannabis company and multi-state operator in the U.S., today announced that it will hold a conference call on Tuesday, August 11, 2020 at 5:00 PM Eastern Time following the release of its second quarter 2020 financial results.

Castlight Health, Inc. (NYSE:CSLT), a leading health benefits platform provider, today announced results for its second quarter ended June 30, 2020.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced that it will release second quarter 2020 financial results after the market closes on Tuesday, August 4, 2020.

Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.

Binovi Technologies Corp., (Binovi) (OTCQB:BNVIF)(TSXV:VISN ), a leader in neuro-vision performance technology announces that further to its news release dated June 29, 2020 the Company is continuing to rely on temporary blanket relief granted by Canadian securities regulators, allowing reporting issuers to extend certain continuous disclosure filing deadlines by 45 days

The Biologic Association has enrolled over 6,000 active clinical members within the first six months of the site launch ( www.thebiologicassociation.com ). The Biologic Association (BA) is an orthopaedic organization dedicated to providing one voice for all matters on musculoskeletal biologics and regenerative medicine. The BA is a co

Adaptive Biotechnologies Corp. (Nasdaq: ADPT) announced today the launch of ImmuneSense Lyme™ , a research study to inform the development of an improved test to detect Lyme disease in the early stages of an infection, when the disease is most treatable but often missed or misdiagnosed. The study calls for approximately 1,000 participants in the Northeast, mid-Atlantic and upper Midwest, where 96% of Lyme cases occur. Participants can be evaluated